Cytomegalovirus (CMV)-specific T cell immunity after renal transplantation mediates protection from CMV disease by limiting the systemic virus load

Journal of Infectious Diseases

Volumn 180, Issue 2, 1999, Pages 247-253

  Reusser, Pierre ^a   Cathomas, Gieri ^b,c   Attenhofer, Rudolf ^a   Tamm, Michael ^a   Thiel, Gilbert ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; FEMALE; HELPER CELL; HUMAN; KIDNEY TRANSPLANTATION; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRUS LOAD;

ADULT; AGED; ANTIGENS, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; DNA, VIRAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; PHYTOHEMAGGLUTININS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, HELPER-INDUCER; VIRAL LOAD;

EID: 0033511580     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314879     Document Type: Article

References (35)

1. 1. Hibberd PL, Tolkoff-Rubin NE, Cosimi AB, et al. Symptomatic cytomegalovirus disease in the cytomegalovirus antibody seropositive renal transplant recipient treated with OKT3. Transplantation 1992;53:68-72.
2. 2. Pillay D, Ali AA, Liu SF, Kops E, Sweny P, Griffiths PD. The prognostic significance of positive CMV cultures during surveillance of renal transplant recipients. Transplantation 1993;56:103-8.
3. 3. Grundy JE, Lui SF, Super M, et al. Symptomatic cytomegalovirus infection in seropositive kidney recipients: reinfection with donor virus rather than reactivation of recipient virus. Lancet 1988;2:132-5.
4. 4. Reusser P. Human cytomegalovirus infection and disease after bone marrow and solid organ transplantation. Bailliere's Clin Infect Dis 1996;3:357-71.
5. 5. Quinnan GV, Kirmani N, Rook AH, et al. Cytotoxic T cells in cytomegalovirus infection: HLA-resticted T-lymphocyte and non T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 1982;307:6-13.
6. 6. Reusser P, Riddell SR, Meyers JD, Greenberg PD. Cytotoxic T lymphocyte response to cytomegalovirus following human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease. Blood 1991;78:1373-80.
7. 7. Reusser P, Attenhofer R, Hebart H, Helg C, Chapuis B, Einsele H. Cytomegalovirus-specific T-cell immunity in recipients of autologous peripheral blood stem cell or bone marrow transplants. Blood 1997;89:3873-9.
8. 8. Li CR, Greenberg PD, Gilbert MJ, Goodrich JM, Riddell SR. Recovery of HLA-restricted cytomegalovirus (CMV)-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 1994;83:1971-9.
9. 9. Rook AH, Quinnan GV, Frederick, et al. Importance of cytotoxic lymphocytes during cytomegalovirus infection in renal transplant recipients. Am J Med 1984;76:385-92.
10. 10. van der Bij W, Torensma R, van Son WJ, Schirm J, Tegzess AM, The TH. Rapid immunodiagnosis of active cytomegalovirus infection by monoclonal antibody staining of blood leukocytes. J Med Virol 1988;25:179-88.
11. 11. Jiwa NM, van Gemert GW, Raap AK, et al. Rapid detection of human cytomegalovirus DNA in peripheral blood leukocytes of viremic transplant recipients by the polymerase chain reaction. Transplantation 1989;48:72-6.
12. 12. van den Berg AP, van der Bij W, van Son WJ. Cytomegalovirus antigenemia as a useful marker of symptomatic cytomegalovirus infection after renal transplantation a report of 130 consecutive patients. Transplantation 1989;48:991-5.
13. 13. Einsele H, Ehninger G, Hebart H, et al. Polymerase chain reaction monitoring reduces the incidence of cytomegalovirus disease and the duration and side effects of antiviral therapy after bone marrow transplantation. Blood 1995;86:2815-20.
14. 14. The TH, van der Ploeg M, van den Berg AP, Vlieger AM, van der Giessen M, van Son WJ. Direct detection of cytomegalovirus in peripheral blood leukocytes: a review of the antigenemia assay and polymerase chain reaction. Transplantation 1992;54:193-8.
15. 15. Meyer-König U, Serr A, von Laer D. Human cytomegalovirus immediate early and late transcripts in peripheral blood leukocytes: diagnostic value in renal transplant recipients. J Infect Dis 1995;171:705-9.
16. 16. Borysiewicz LK, Morris S, Page JD, Patrick Sissons JG. Human cytomegalovirus-specific cytotoxic T lymphocytes: requirements for in vitro generation and specificity. Eur J Immunol 1983;13:804-9.
17. 17. Laubscher A, Bluestein HG, Spector SA, Zvaifler NJ. Generation of human cytomegalovirus-specific cytotoxic T lymphocytes in a short-term culture. J Immunol Methods 1988;110:69-77.
18. 18. Riddell SR, Greenberg PD. The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells. J Immunol Methods 1990;128:189-201.
19. 19. Riddell SR, Rabin M, Geballe AP, Britt WJ, Greenberg PD. Class I MHC-restricted cytotoxic T lymphocyte recognition of cells infected with human cytomegalovirus does not require endogenous viral gene expression. J Immunol 1991;146:2795-804.
20. 20. Gehrz RC, Fuad S, Liu YNC, Bach FH. HLA class II restriction of T helper cell response to cytomegalovirus. J Immunol 1987;138:3145-51.
21. 21. Chou S. Effect of interstrain variation on diagnostic DNA amplification of the cytomegalovirus major immediate-early gene region. J Clin Microbiol 1992;30:2307-10.
22. 22. Snydman DR, Werner BG, Heinze-Lacey B, et al. Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. N Engl J Med 1987;317:1049-54.
23. 23. Balfour HH Jr, Chace BA, Stapleton JT, Simmons RL, Fryd DS. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 1989;320:1381-7.
24. 24. Hibberd PL, Tolkoff-Rubin NE, Conti D, et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients: a randomized controlled trial. Ann Intern Med 1995;123:18-26.
25. 25. Grefte JMM, van der Gun BTF, Schmolke S, et al. The lower matrix protein pp65 is the principal viral antigen present in peripheral blood leukocytes during an active cytomegalovirus infection. J Gen Virol 1992;73:2923-32.
26. 26. Gilbert MJ, Riddell SR, Li CR, Greenberg PD. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J Virol 1993;67:3461-9.
27. - virus-specific cytotoxic T lymphocytes. J Med Virol 1994;43: 103-10.
28. 28. van Zanten J, Harmsen MC, van der Meer P, et al. Proliferative T cell responses to four human cytomegalovirus-specific proteins in healthy subjects and solid organ transplant recipients. J Infect Dis 1995;172:879-82.
29. 29. Forman SJ, Zaia JA, Clark BR, et al. A 64,000 dalton matris protein of human cytomegalovirus induces in vitro immune responses similar to those of whole viral antigen. J Immunol 1985;134:3391-5.
30. 30. Beninga J, Kropff B, Mach M. Comparative analysis of fourteen individual human cytomegalovirus proteins for helper T cell response. J Gen Virol 1995;76:153-60.
31. 31. Khattab BAM, Lindenmaier W, Frank R, Link H. Three T-cell epitopes within the C-terminal 265 amino acids of the matrix protein pp65 of human cytomegalovirus recognized by human lymphocytes. J Med Virol 1997;52:68-76.
32. 32. Walter EA, Greenberg PD, Gilbert MJ, et al. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 1995;333: 1038-44.
33. 33. Daniels JC, Sakai H, Remmers AR Jr, et al. In vitro reactivity of human lymphocytes in chronic uraemia: analysis and interpretation. Clin Exp Immunol 1971;8:213-27.
34. 34. Newberry WM, Sanford JP. Defective cellular immunity in renal failure: depression of reactivity of lymphocytes to phytohemagglutinin by renal failure serum. J Clin Invest 1971;50:1262-71.
35. 35. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 1992;257:238-41.